Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome
Ying Li, Gaichao Hong, Min Jae Yang, Gangping Li, Yu Jin, Hanhua Xiong, Wei Qian, Xiaohua Hou
Topics & Concepts
RifaximinIrritable bowel syndromeGastroenterologyFecesDysbiosisDiarrheaInternal medicineMedicineGut floraSmall intestinal bacterial overgrowthBifidobacteriumLactobacillusBacteriaMicrobiologyAntibioticsBiologyImmunologyDiseaseGeneticsGut microbiota and healthGastrointestinal motility and disordersClostridium difficile and Clostridium perfringens research